TIMOLOL METABOLISM AND DEBRISOQUINE OXIDATION POLYMORPHISM - A POPULATION STUDY

被引:10
作者
LENNARD, MS
LEWIS, RV
BRAWN, LA
TUCKER, GT
RAMSAY, LE
JACKSON, PR
WOODS, HF
机构
基金
英国惠康基金;
关键词
D O I
10.1111/j.1365-2125.1989.tb05390.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:429 / 434
页数:6
相关论文
共 13 条
[1]  
Clarke E.G.C., 1986, ISOLATION IDENTIFICA
[2]   BRADYCARDIA INDUCED BY INTERACTION BETWEEN QUINIDINE AND OPHTHALMIC TIMOLOL [J].
DINAI, Y ;
SHARIR, M ;
NAVEH, N ;
HALKIN, H .
ANNALS OF INTERNAL MEDICINE, 1985, 103 (06) :890-891
[3]   OCULAR BETA-BLOCKERS AND SYSTEMIC EFFECTS [J].
FRAUNFELDER, FT .
ARCHIVES OF INTERNAL MEDICINE, 1986, 146 (06) :1073-1074
[4]  
JACKSON PR, 1988, THESIS U SHEFFIELD
[5]   TIMOLOL DETERMINATION IN PLASMA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION [J].
LENNARD, MS ;
PARKIN, S .
JOURNAL OF CHROMATOGRAPHY, 1985, 338 (01) :249-252
[6]   OXIDATION PHENOTYPE - A MAJOR DETERMINANT OF METOPROLOL METABOLISM AND RESPONSE [J].
LENNARD, MS ;
SILAS, JH ;
FREESTONE, S ;
RAMSAY, LE ;
TUCKER, GT ;
WOODS, HF .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (25) :1558-1560
[7]   TIMOLOL AND ATENOLOL - RELATIONSHIPS BETWEEN OXIDATION PHENOTYPE, PHARMACOKINETICS AND PHARMACODYNAMICS [J].
LEWIS, RV ;
LENNARD, MS ;
JACKSON, PR ;
TUCKER, GT ;
RAMSAY, LE ;
WOODS, HF .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 19 (03) :329-333
[8]   PHARMACOKINETICS AND BETA-BLOCKING EFFECTS OF TIMOLOL IN POOR AND EXTENSIVE METABOLIZERS OF DEBRISOQUIN [J].
MCGOURTY, JC ;
SILAS, JH ;
FLEMING, JJ ;
MCBURNEY, A ;
WARD, JW .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (04) :409-413
[9]   METOPROLOL METABOLISM AND DEBRISOQUINE OXIDATION POLYMORPHISM - POPULATION AND FAMILY STUDIES [J].
MCGOURTY, JC ;
SILAS, JH ;
LENNARD, MS ;
TUCKER, GT ;
WOODS, HF .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 20 (06) :555-566
[10]   SEVERE BRADYCARDIA DUE TO INTERACTION OF TIMOLOL EYE DROPS AND VERAPAMIL [J].
PRINGLE, SD ;
MACEWEN, CJ .
BRITISH MEDICAL JOURNAL, 1987, 294 (6565) :155-156